Content ID


What is today’s news | Wednesday, February 16, 2022

We’re halfway through the week! In case you missed anything so far, catch up on the latest news.

From avian influenza to ethanol studies, below is a roundup of the headlines to help keep you informed.

Livestock news

A second case of avian influenza was reported to state officials in Dubois County, Indiana, on Tuesday. These cases are the first in Indiana since 2016, and have resulted in the depopulation of over 50,000 turkeys. 

Officials encourage producers to know the signs of avian influenza and report suspected cases to their local veterinarians or to the USDA’s Healthy Birds Hotline. 

The 2022 Animal AgTech Innovation Summit brings with it a host of new start-ups, all ready to help solve problems in various areas of livestock production. 

At the Summit on March 21, the 10 innovators will have a chance to demonstrate their solutions at the Start-Up Pitching Session.

The latest in crops

Editor Chelsea Dinterman covers Syngenta’s new herbicide, Tendovo, and its registration with the EPA.

Syngenta trials concluded Tendovo provided more than 95% control of pigweeds and grass weeds compared with competitive herbicides. In those trials, fields treated with Tendovo canopied more quickly and had better stands.

Industry experts are discrediting a study that alleges corn-based ethanol causes more damage to the environment than regular gasoline. 

Monte Shaw, Iowa Renewable Fuels Association executive director, says this study isn’t worth his or anybody else’s time to consider.

Editor Laurie Bedord writes about the newest addition to AgLeader’s DirectCommand line: the RightSpot. 

Managed through the InCommand 1200 display, RightSpot controls flow rate and pressure independently. Individual pulsing nozzles maintain a consistent, user-defined boom pressure across a wide range of speeds.

​​​​New developments in short-stature corn, biologicals, and digital agriculture just top the list of new idea coming from Bayer’s research and development. Editor Gil Gullickson covers a few of the highlights.

The research and development pipeline is valued at up to 30 billion euros ($34.13 billion) in peak sales potential over the next two decades, say Bayer officials.

Read more about

Talk in Marketing